The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People 'Lost to Follow Up'
- PMID: 39005529
- PMCID: PMC11245707
- DOI: 10.1093/phe/phae006
The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People 'Lost to Follow Up'
Abstract
Hepatitis C is a global public health threat, affecting 56 million people worldwide. The World Health Organization has committed to eliminating hepatitis C by 2030. Although new treatments have revolutionised the treatment and care of people with hepatitis C, treatment uptake has slowed in recent years, drawing attention to the need for innovative approaches to reach elimination targets. One approach involves using existing notifiable disease data to contact people previously diagnosed with hepatitis C. Within these disease surveillance systems, however, competing tensions exist, including protecting individual rights to privacy and autonomy, and broader public health goals. We explore these issues using hepatitis C and Australia's legislative and regulatory frameworks as a case study. We examine emerging uses of notification data to contact people not yet treated, and describe some of the ethical dilemmas associated with the use and non-use of this data and the protections that exist to preserve individual rights and public health. We reveal weaknesses in rights protections and processes under Australian public health and human rights legislation and argue for consultation with and involvement of affected communities in policy and intervention design before notification data is used to increase hepatitis C treatment coverage.
© The Author(s) 2024. Published by Oxford University Press.
Similar articles
-
"It's time!": A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C.Int J Drug Policy. 2021 Nov;97:103280. doi: 10.1016/j.drugpo.2021.103280. Epub 2021 May 28. Int J Drug Policy. 2021. PMID: 34058670
-
Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era.Int J Drug Policy. 2023 Sep;119:104142. doi: 10.1016/j.drugpo.2023.104142. Epub 2023 Aug 15. Int J Drug Policy. 2023. PMID: 37591009
-
The Elimination of Hepatitis C as a Public Health Threat.Cold Spring Harb Perspect Med. 2020 Apr 1;10(4):a036939. doi: 10.1101/cshperspect.a036939. Cold Spring Harb Perspect Med. 2020. PMID: 31712223 Free PMC article. Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Future directions for notifiable diseases: tuberculosis-related laws in the Philippines.Global Health. 2018 Aug 22;14(1):87. doi: 10.1186/s12992-018-0405-2. Global Health. 2018. PMID: 30134993 Free PMC article. Review.
References
-
- Andaluz, I., del Mar Arcos, M., Montero, M. D., Castillo, P., Martin-Carbonero, L. and Garcia-Samaniego, J. (2020). Patients with Hepatitis C Lost to Follow-Up: Ethical-Legal Aspects and Search Results. Revista Espanola de Enfermadades Digestivas (REED), 112, 532–538. doi: 10.17235/reed.2020.7077/2020 - DOI - PubMed
-
- Bayer, R. and Fairchild, A. (2000). The Role of Name-Based Notification in Public Health and HIV Surveillance. Geneva: Joint United Nations Programme on HIV/AIDS, available from: https://www.unaids.org/sites/default/files/media_asset/jc338-name-based_... [accessed 16 November 2022].
-
- Blach, S., Terrault, N. A., Tacke, F., Gamkrelidze, I., Craxi, A., Tanaka, J., Waked, I., Dore, G. J., Abbas, Z., Abdallah, A. R. and Abdulla, M. (2022). Global Change in Hepatitis C Virus Prevalence and Cascade of Care Between 2015 and 2020: A Modelling Study. The Lancet Gastroenterology & Hepatology, 7, 396–415. doi: 10.1016/S2468-1253(21)00472-6 - DOI - PubMed
LinkOut - more resources
Full Text Sources